Lv1
92 积分 2024-10-29 加入
A Glutathione‐Responsive System with Prodrug and Sensitization Strategies for Targeted Therapy of Glioma
4天前
已完结
Novel Amphiphilic PROTAC with Enhanced Pharmacokinetic Properties for ALK Protein Degradation
4天前
已完结
Carrier-free nano-prodrugs for enhanced cancer therapy: stimuli-responsive design and applications
4天前
已完结
Carrier-free nano-prodrugs for minimally invasive cancer therapy
4天前
已完结
Progress of CDK4/6 Inhibitor Palbociclib in the Treatment of Cancer
5天前
已完结
Design, synthesis, and biological evaluation of novel CDK4/6 and BRD4 dual inhibitors for treatment of KRAS-mutant NSCLC
5天前
已完结
Cyclin D–CDK4 kinase destabilizes PD-L1 via cullin 3–SPOP to control cancer immune surveillance
11天前
已完结
Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
12天前
已完结
Reactive Oxygen Species and Glutathione Dual Redox-Responsive Supramolecular Assemblies with Controllable Release Capability
19天前
已完结
CDK4/6 Inhibition Promotes Antitumor Immunity through the Induction of T-cell Memory
26天前
已完结
皖公网安备34019202002308
